Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Patterson

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Virology|January 18, 2013
Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDSMonica Vaccari, Rabih Halwani, L Jean Patterson, et al.
Journal of Virology|January 19, 2007
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaquesThorsten Demberg, Ruth H Florese, Megan J Heath, et al.
Virology|January 18, 2011
Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challengeL Jean Patterson, Mara Daltabuit-Test, Peng Xiao, et al.
Clinical Immunology (Orlando, Fla.)|September 18, 2014
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaquesAntonio Valentin, Katherine McKinnon, Jinyao Li, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2014
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responsesDiego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, et al.
Plos Pathogens|July 6, 2021
Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaquesKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Virology|January 18, 2013
Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDSMonica Vaccari, Rabih Halwani, L Jean Patterson, et al.
Journal of Virology|January 19, 2007
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaquesThorsten Demberg, Ruth H Florese, Megan J Heath, et al.
Virology|January 18, 2011
Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challengeL Jean Patterson, Mara Daltabuit-Test, Peng Xiao, et al.
Clinical Immunology (Orlando, Fla.)|September 18, 2014
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaquesAntonio Valentin, Katherine McKinnon, Jinyao Li, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2014
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responsesDiego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, et al.
Plos Pathogens|July 6, 2021
Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaquesKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Pageof 5